Leukemic phase and CSF involvement of diffuse large B‐cell lymphoma with a complex karyotype including a TP53 deletion

By  

Clinical Case Reports, Vol. 6, Iss. 1, 2018-01 ,pp. : 235-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments: An Observational Study

By Mazzotta Annamaria   Esposito Maria   Costanzo Antonio   Chimenti Sergio  

American Journal of Clinical Dermatology, Vol. 10, Iss. 5, 2009-10 ,pp. : 319-324

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Plaque Psoriasis and Psoriatic Arthritis

By Goldsmith David R.   Wagstaff Antona J.  

BioDrugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 401-403

Adis International

Access to resources Recommend Favorite

Efalizumab Therapy for Psoriasis in Patients with Inadequate Responses to Etanercept

By Kramer Jesse M.  

American Journal of Clinical Dermatology, Vol. 10, Iss. 2, 2009-01 ,pp. : 134-140

Adis International

Access to resources Recommend Favorite

An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis

By Weinberg J.M.  

Clinical Therapeutics, Vol. 25, Iss. 10, 2003-10 ,pp. : 2487-2505

Elsevier

Access to resources Recommend Favorite